Fibroblast growth factor 23 overexpression impacts negatively on dentin mineralization and dentinogenesis in mice

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 6, 2011, Pages 395-402

  Chen, Ling ^a   Liu, Hong ^b   Sun, Wen ^b   Bai, Xiuying ^c   Karaplis, Andrew C ^c   Goltzman, David ^d   Miao, Dengshun ^b  

^a THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Dentin formation; Dentin mineralization; Fibroblast growth factor 23; Transgenic mice

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 23; OSTEOCALCIN; SIALOPROTEIN;

ALVEOLAR BONE; AMELOBLAST; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORTICAL BONE; DENTIN; INCISOR; MOLAR TOOTH; MOUSE; NEWBORN; NONHUMAN; ODONTOBLAST; TOOTH DEVELOPMENT; TRANSGENIC MOUSE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; DENTIN; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; MANDIBLE; MICE; MICE, TRANSGENIC; PHOSPHOPROTEINS; RNA, MESSENGER; SIALOGLYCOPROTEINS; TOOTH CALCIFICATION;

EID: 79956312440     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05526.x     Document Type: Article

References (27)

1. White KE, Evans WE, O'Riordan JLH et al Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 2000; 26: 345-8.
2. Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl Acad. Sci. USA 2001; 98: 6500-5.
3. Francis F, Hennig S, Korn B et al A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat. Genet. 1995; 11: 130-6.
4. Feng JQ, Ward LM, Liu S et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 2006; 38: 1310-5.
5. Lorenz-Depiereux B, Bastepe M, Benet-Pages A et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 2006; 38: 1248-50.
6. Beck L, Soumounou Y, Martel J et al. Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice. J. Clin. Invest. 1997; 99: 1200-9.
7. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 2006; 291: E38-49.
8. Abe K, Ooshima T, Lily TS, Yasufuku Y, Sobue S. Structural deformities of deciduous teeth in patients with hypophosphatemic vitamin D-resistant rickets. Oral Surg. Oral Med. Oral Pathol. 1988; 65: 191-8.
9. Goodman JR, Gelbier MJ, Bennett JH, Winter GB. Dental problems associated with hypophosphataemic vitamin D resistant rickets. Int. J. Paediatr. Dent. 1998; 8: 19-28.
10. Eicher EM, Southard JL, Scriver CR, Glorieux FH. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc. Natl. Acad. Sci. USA 1976; 73: 4667-71.
11. Fong H, Chu EY, Tompkins KA et al. Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse. J. Periodontol. 2009; 80: 1348-54.
12. Ye L, MacDougall M, Zhang S et al. Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J. Biol. Chem. 2004; 279: 19141-8.
13. Jiang B, Cao Z, Lu Y et al. DMP1 C-terminal mutant mice recapture the human ARHR tooth phenotype. J. Bone Miner. Res. 2010; 25: 2155-64.
14. Onishi T, Umemura S, Shintani S, Ooshima T. Phex mutation causes overexpression of FGF23 in teeth. Arch. Oral Biol. 2008; 53: 99-104.
15. Bai X, Miao D, Li J, Goltzman D, Karaplis AC. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004; 145: 5269-79.
16. Larsson T, Marsell R, Schipani E et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004; 145: 3087-94.
17. Liu H, Guo J, Wang L et al. Distinctive anabolic roles of 1, 25-dihydroxyvitamin D3 and parathyroid hormone in teeth and mandible versus long bones. J. Endocrinol. 2009; 203: 203-13.
18. Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D. Genetic models show that parathyroid hormone and 1, 25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum. Mol. Genet. 2005; 14: 1515-28.
19. Sreenath T, Thyagarajan T, Hall B et al. Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III. J. Biol. Chem. 2003; 278: 24874-80.
20. Qin C, Brunn JC, Cadena E, Ridall A, Butler WT. Dentin sialoprotein in bone and dentin sialophosphoprotein gene expressed by osteoblasts. Connect. Tissue Res. 2003; 44 (Suppl. 1): 179-83.
21. Yonaga T. Action of parathyroid hormone, with special reference to its anabolic effect on different kinds of tissues in rats (II). Bull. Tokyo Med. Dent. Univ. 1978; 25: 249-58.
22. Lee SK, Kim YS, Oh HS, Yang KH, Kim EC, Chi JG. Prenatal development of the human mandible. Anat. Rec. 2001; 263: 314-25.
23. Ogawa T, Onishi T, Hayashibara T, Sakashita S, Okawa R, Ooshima T. Dentinal defects in Hyp mice not caused by hypophosphatemia alone. Arch. Oral Biol. 2006; 51: 58-63.
24. Sitara D, Kim S, Razzaque MS et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet. 2008; 4: e1000154.
25. Chu EY, Fong H, Blethen FA et al. Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex. Anat. Rec. (Hoboken) 2010; 293: 1214-26.
26. Ye L, Mishina Y, Chen D et al. Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J. Biol. Chem. 2005; 280: 6197-203.
27. Liu S, Zhou J, Tang W, Menard R, Feng JQ, Quarles LD. Pathogenic role of Fgf23 in Dmp1-null mice. Am. J. Physiol. Endocrinol. Metab. 2008; 295: E254-61.